Episode 14: Twitter vitriol, biotech jargon, and the plight of the CEO

The Readout Loud - A podcast by STAT - Thursdays

Why is Twitter so mean to Axovant? Adam teaches a crash course on biostatistics. And will sci-fi gene and cell therapies ever go mainstream.